Unipharma Co., Ltd. financial statements
Unipharma Co., Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | TWD 88.44M | EODHD |
| Net income | −TWD 40.54M | EODHD |
| Cash and equivalents | TWD 29M | EODHD |
Unipharma Co., Ltd. financials on 6ix · Unipharma Co., Ltd. on 6ix